D-Flexâ„¢ Injection Pen

D-Flexâ„¢ Injection Pen
Product Description

D-Flexâ„¢, the pen platform for subcutaneous self-injection. Bridging the gap between fixed and variable-dose pens, this innovative product also paves the way for connected commercial devices.Just one pen for many needs: Disposable pen for fixed or multiple fixed dosagesThe versatile solution: Allows manual, multiple injections with only a single penSafe to use for patients: Patients cannot set unintended dosagePerfect for clinical trials: Easy and flexible adaptation to different dose requirementsNetwork-ready: Allows for connectivity and smart data processingLow investment cost: Faster product development based on a platform





The products shown on this website are under development and some of them may not yet have been approved for sale under applicable medical devices regulation. The content provides general information about these products, their field of application and intended use, and their function, performance and specification are subject to customer specific development and may deviate from those shown herein. All information contained herein is directed at medical devices manufacturer and pharmaceutical companies. This information shall not constitute a promotion for use in a way which conflicts with any applicable medical devices regulation nor is it directed at patients or intended to replace professional medical advice.



Haselmeier

  • DE
  • 2021
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Drug delivery device Supplier/Manufacturer
Engineering
Manufacturer/Innovator
Primary activities
Medical Devices
Packaging & drug delivery

Haselmeier

  • DE
  • 2021
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Drug delivery device Supplier/Manufacturer
Engineering
Manufacturer/Innovator
Primary activities
Medical Devices
Packaging & drug delivery

More Products from Haselmeier (4)

  • PiccoJect™ Autoinjector

    Product PiccoJect™ Autoinjector

    PiccoJect™ is a highly compact, customizable and fully featured two-step autoinjector designed for subcutaneous delivery of drug products.
    • Extremely low part count: Only 8 parts in total – reduces manufacturing and scale up challenges • Ergonomic shape & small size: Thanks to its compact flat ...
  • D-Flex™ Injection Pen

    Product D-Flex™ Injection Pen

    D-Flex™, the pen platform for subcutaneous self-injection. Bridging the gap between fixed and variable-dose pens, this innovative product also paves the way for connected commercial devices.
    • Just one pen for many needs: Disposable pen for fixed or multiple fixed dosages • The versatile solution: All...
  • Connected Solutions

    Product Connected Solutions

    D-Flex™ Logbook – From data to value
    The D-Flex™ Logbook collects treatment data at the point of care, without the need for a patient app or mobile phone. The D-Flex™ Logbook consists of the disposable D-Flex injection pen and the connected cap, which replaces the standard cap of the pen. Patients rem...
  • Re-Vario™ & Re-Vario™ A Injection Pens

    Product Re-Vario™ & Re-Vario™ A Injection Pens

    The Re-Vario is a re-usable pen platform with a anodized aluminium body to provide years of reliability. The Re-Vario™ A is a high quality, plastic re-usable pen.

    The product platform (Re-Vario™ / Re-Vario™ A) is the basis for a re-usable, variable dose injection device designed for use...

Haselmeier resources (4)

  • Brochure PiccoJect Product Brochure

    PiccoJect™ is a highly compact, customizable and fully featured two-step autoinjector designed for subcutaneous delivery of drug products.Extremely low part counrtLarge wrap-around drug window with customizable sizeOptimized spring forcesFuture proofCommitted to sustainabilityErgonomic shape & small sizeColored status indicatorAudible clicks at the start and end of injectionAny standard 1 ml or 2.25 ml pre-filled syringeA full-service platform
    The products shown in this video are under development and some of them may not yet have been approved for sale under applicable medical device regulations. The concept provides general information about these products, their field of application and intended use, and their function, performance and specification are subject to customer specific development and may deviate from those shown herein. All information contained herein is directed at medical device manufacturers and pharmaceutical companies. This information shall not constitute a promotion for use in a way which conflicts with any applicable medical device regulations, nor is it directed at patients or intended to replace professional medical advice.
  • Whitepaper Excellence through Simplicity – PiccoJect™ Autoinjector

    Effective self-management of chronic diseases requires healthcare solutions that are easy and convenient for patients. This is one of the key drivers for our patient-focused development of innovative drug delivery solutions.
    The simplicity of PiccoJect™, combined with our sustainability philosophy, is reflected in the entire supply chain to reduce waste and minimize environmental impacts. In addition to investing in green electricity and the use of sustainable feedstocks, we focus on the development of regional supply chains for the US and European markets. 'Excellence through simplicity' sums up our patient-centered and sustainable philosophy.


    The products shown in this video are under development and some of them may not yet have been approved for sale under applicable medical device regulations. The concept provides general information about these products, their field of application and intended use, and their function, performance and specification are subject to customer specific development and may deviate from those shown herein. All information contained herein is directed at medical device manufacturers and pharmaceutical companies. This information shall not constitute a promotion for use in a way which conflicts with any applicable medical device regulations, nor is it directed at patients or intended to replace professional medical advice.
  • Video PiccoJect Video

    PiccoJect™ is a highly compact, customizable and fully featured two-step autoinjector designed for subcutaneous delivery of drug products.Extremely low part counrtLarge wrap-around drug window with customizable sizeOptimized spring forcesFuture proofCommitted to sustainabilityErgonomic shape & small sizeColored status indicatorAudible clicks at the start and end of injectionAny standard 1 ml or 2.25 ml pre-filled syringeA full-service platform
    The products shown in this video are under development and some of them may not yet have been approved for sale under applicable medical device regulations. The concept provides general information about these products, their field of application and intended use, and their function, performance and specification are subject to customer specific development and may deviate from those shown herein. All information contained herein is directed at medical device manufacturers and pharmaceutical companies. This information shall not constitute a promotion for use in a way which conflicts with any applicable medical device regulations, nor is it directed at patients or intended to replace professional medical advice.
  • Webinar Case Study: Importance of Simulation and Modeling in Autoinjector Development

    In this webinar, originally broadcast as part of Pharmapack Europe 2022, Chris Muenzer, Vice President of Innovation & Development, Haselmeier, a medmix Brand discusses how development of an integrated drug delivery device is a complex exercise that requires expertise in medical device engineering and pharmaceutical science. Health authorities expect legal manufactures to have a strategy to control device performance through the entire supply. Modeling and simulation is an important tool to ensure robust and repeatable performance while maintaining time to market. This case study looks at how Haselmeier is applying these techniques during the creation of a new autoinjector platform. In addition, Chris will look at future opportunities for further improvements though expanded use of digital twins and other technologies.